Clinical Trial Update: PF-06669571 In Subjects With Idiopathic Parkinson's Disease [Phase 1]

View source ↗

Summary

Phase 1 trial update for PF-06669571 in idiopathic Parkinson's disease; study completed with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Parkinson Disease

Drugs mentioned

• PF-06669571 (PF-06669571)

Snippet

Sponsor: Pfizer | Conditions: Idiopathic Parkinson's Disease | Phase 1 | Status: COMPLETED | Results posted: 2017-08-07